Focus on Asthma Care

Back to articles

Albuterol inhaler costs soared after FDA ban on CFC inhalers

KEY POINT

Among privately insured patients, FDA’s ban on chlorofluorocarbon (CFC) albuterol inhalers resulted in higher out-of-pocket costs and modest declines in inhaler use, according to results of a new analysis published in JAMA Internal Medicine.